Part III CARTAGENA PROTOCOL
United Kingdom
The application shall provide the information required under Articles 5(3)(c) and 17(3)(c) of Regulation (EC) No 1829/2003 for the purpose of complying with Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity.
The provided information shall contain as a minimum the information specified in Annex II to Regulation (EC) No 1946/2003 of the European Parliament and of the Councilf1:
- (a)
The name and contact details of the applicant for a decision for domestic use;
- (b)
The name and contact details of the authority responsible for the decision;
- (c)
Name and identity of the GMO;
- (d)
Description of the gene modification, the technique used, and the resulting characteristics of the GMO;
- (e)
Any unique identification of the GMO;
- (f)
Taxonomic status, common name, point of collection or acquisition, and characteristics of recipient organism or parental organisms related to biosafety;
- (g)
Centres of origin and centres of genetic diversity, if known, of the recipient organism and/or the parental organisms and a description of the habitats where the organisms may persist or proliferate;
- (h)
Taxonomic status, common name, point of collection or acquisition, and characteristics of the donor organism or organisms related to biosafety;
- (i)
Approved uses of the GMO;
- (j)
A risk assessment report consistent with Annex II to Directive 2001/18/EC;
- (k)
Suggested methods for the safe handling, storage, transport and use, including packaging, labelling, documentation, disposal and contingency procedures, where appropriate.